AstraZeneca Pharma tumbled 5.12% to Rs 6,768 after the pharmaceutical firm's net profit declined 26.62% to Rs 38.43 crore in Q2 FY25 as compared with Rs 52.37 crore posted in Q2 FY24.

The 52-week high of the counter is Rs 1,152.80 and the 52-week low of the scrip is Rs 19.59. The company has a market cap of ...

National Aluminium Company or NALCO shares gained in the morning deals on November 14 after the state-owned metals player ...

Shares of Apollo Tyres ended a four-day losing streak with a nearly 5 percent rise on November 14, following a quarterly ...

Brokerages retained their bullish view on Signature Global [Signatureglobal (India)] after it posted a consolidated profit of ...

Ashish Bhandari, MD and CEO of Thermax, remains cautiously optimistic about the second half of the year, hoping to see these ...

Deepak Nitrite Q2 Results 2024:Deepak Nitrite declared their Q2 results on 13 Nov, 2024, revealing a mixed performance for ...

Revenue increased by 19.75% YoY & profit increased by 53.43% YoY, profit at ₹122.12 crore and revenue at ₹2458.73 crore.

TOKYO :Mizuho Financial Group reported a 62 per cent jump in second-quarter net profit and lifted its annual guidance on ...

ET Now | Century Ply, earnings report, there is a notable recovery in the Medium Density Fiberboard (MDF) segment. Keshav ...

The rise in Lumax Auto share price came after the company posted a strong set of numbers in the September quarter of ...